ストックスクリーナーアプリを入手
0.97
0.00%
0.005
前日終値:
$0.975
開ける：
$0.9457
24時間の取引高:
7,782
Relative Volume:
0.05
時価総額：
$61.19M
収益：
$33.79M
当期純損益:
$-18.67M
株価収益率:
-2.708
EPS:
-0.3582
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
-1.02%
1か月 パフォーマンス:
-2.30%
6か月 パフォーマンス:
+3.72%
1年 パフォーマンス:
-13.72%
1日の値動き範囲:
$0.9457
$0.9999
1週間の範囲:
$0.9352
$1.02
52週間の値動き範囲:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
CTSO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.975 | 61.19M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
134.91 | 233.69B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.39 | 143.42B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
374.29 | 143.48B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
97.36 | 125.54B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 44.47B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2020-09-17 | 開始されました | Jefferies | Buy |
| 2020-09-01 | 開始されました | SVB Leerink | Outperform |
| 2017-08-08 | 繰り返されました | Maxim Group | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-05-24 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 繰り返されました | MLV & Co | Buy |
| 2015-04-01 | 繰り返されました | MLV & Co | Buy |
| 2015-03-05 | 開始されました | MLV & Co | Buy |
| 2015-02-25 | 開始されました | WBB Securities | Speculative Buy |
| 2015-01-27 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Cytosorbents Corp (CTSO) 最新ニュース
What is the fair value estimate for Cytosorbents Corporation (HQE1) stock in 2025IPO Watch & Accurate Technical Buy Alerts - newser.com
Published on: 2025-10-06 01:54:06 - newser.com
Is Cytosorbents Corporation (HQE1) stock vulnerable to rate hikesJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Published on: 2025-10-06 00:49:59 - newser.com
What machine learning models say about Cytosorbents CorporationQuarterly Portfolio Review & Risk Controlled Daily Trade Plans - newser.com
Custom watchlist performance reports with Cytosorbents CorporationWeekly Profit Analysis & Fast Entry and Exit Trade Plans - newser.com
Why retail traders accumulate Cytosorbents Corporation (HQE1) stockWeekly Profit Analysis & Growth Focused Investment Plans - newser.com
Can Cytosorbents Corporation stock beat market expectations this quarterBear Alert & Fast Gain Swing Alerts - newser.com
Is Cytosorbents Corporation (HQE1) stock worth buying before Fed actionJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
Cytosorbents receives Nasdaq notice for non-compliance with minimum bid price - Investing.com
Is Cytosorbents Corporation forming a bottoming base2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
Is it time to cut losses on Cytosorbents CorporationWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Order flow analysis tools used on Cytosorbents CorporationWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Cytosorbents Corporation $CTSO Shares Bought by Goldman Sachs Group Inc. - Defense World
Will Cytosorbents Corporation (HQE1) stock beat value stocks2025 Investor Takeaways & Risk Managed Trade Strategies - newser.com
Does Cytosorbents Corporation show high probability of reboundTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen - Eastern Progress
Why Cytosorbents Corporation (HQE1) stock is trending on social media2025 Top Decliners & AI Optimized Trading Strategy Guides - newser.com
Is Cytosorbents Corporation building a consolidation base2025 Short Interest & Stock Market Timing Techniques - newser.com
Can Cytosorbents Corporation (HQE1) stock survive global slowdown2025 Pullback Review & AI Driven Price Forecasts - newser.com
First Randomized Trial Data: CytoSorbents' DrugSorb-ATR Shows Success in Urgent Cardiac Surgery Safety - Stock Titan
Published on: 2025-09-27 14:19:40 - newser.com
Cytosorbents Corporation stock trend forecastJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Published on: 2025-09-25 10:35:40 - newser.com
Published on: 2025-09-21 21:39:05 - newser.com
What does recent volatility data suggest for Cytosorbents CorporationTrade Risk Summary & Comprehensive Market Scan Insights - newser.com
Price Action: What is the next catalyst for Cytosorbents CorporationMarket Volume Report & Verified Chart Pattern Trade Signals - خودرو بانک
Quantitative breakdown of Cytosorbents Corporation recent moveMarket Activity Report & Smart Swing Trading Techniques - newser.com
What to expect from Cytosorbents Corporation in the next 30 daysPortfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Cytosorbents Corp (CTSO) 財務データ
収益
当期純利益
現金流量
EPS
2.12%
0.09%
大文字化:
|
ボリューム (24 時間):